KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹124 Cr | ₹141 Cr | ₹115 Cr | ₹110 Cr | ₹114 Cr |
What is the latest Total Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹110 Cr |
| Mar2021 | ₹114 Cr |
How is Total Liabilities of KERALA AYURVEDA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -11.88 | |
| Mar2024 | ₹141 Cr | 22.14 | |
| Mar2023 | ₹115 Cr | 4.68 | |
| Mar2022 | ₹110 Cr | -3.36 | |
| Mar2021 | ₹114 Cr | - | |
Compare Total Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹268.5 Cr | 3.4% | -10% | -49.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | 3.4% |
-10% |
-49.6% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses